
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Valuation
AI Summary
- About
Aclarion Inc (ACON)



- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)


(see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
02/20/2025: ACON (1-star) is currently NOT-A-BUY. Pass it for now.
Analysis of Past Performance
Type Stock | Historic Profit -84.39% | Avg. Invested days 25 | Today’s Advisory PASS |
Upturn Star Rating ![]() ![]() | Upturn Advisory Performance ![]() | Stock Returns Performance ![]() |
![]() ![]() | ![]() ![]() |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 5.35M USD | Price to earnings Ratio - | 1Y Target Price 435.5 |
Price to earnings Ratio - | 1Y Target Price 435.5 | ||
Volume (30-day avg) 748638 | Beta 0.33 | 52 Weeks Range 3.86 - 164.15 | Updated Date 02/20/2025 |
52 Weeks Range 3.86 - 164.15 | Updated Date 02/20/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -804.49 |
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin - | Operating Margin (TTM) -8995.34% |
Management Effectiveness
Return on Assets (TTM) -127.69% | Return on Equity (TTM) -745.47% |
Valuation
Trailing PE - | Forward PE - | Enterprise Value 4186045 | Price to Sales(TTM) 108.62 |
Enterprise Value 4186045 | Price to Sales(TTM) 108.62 | ||
Enterprise Value to Revenue 84.93 | Enterprise Value to EBITDA -0.56 | Shares Outstanding 1015890 | Shares Floating 30715 |
Shares Outstanding 1015890 | Shares Floating 30715 | ||
Percent Insiders - | Percent Institutions - |
AI Summary
Aclarion Inc. - A Comprehensive Overview
Company Profile:
Detailed History and Background:
Aclarion Inc. (Nasdaq: CLRN) is a US-based company founded in 1994 and headquartered in Mountain View, California. Initially known as Interclaim, the company rebranded to Aclarion in 2015. Aclarion specializes in cloud-based solutions for enterprise contract management and legal spending analysis. They cater to a diverse range of industries, including healthcare, technology, life sciences, and professional services.
Core Business Areas:
Aclarion operates in two primary segments:
- Enterprise Contract Management (ECM): Aclarion's ECM solution streamlines the entire contract lifecycle, from drafting to negotiation and execution. It also includes features like automated renewal reminders, self-service portals for easy access, and robust reporting capabilities.
- Legal Spend Analysis: Aclarion's legal spend analysis tool helps corporations optimize their legal spending by providing deep insights into invoice data, matter details, and legal vendor performance. This offering enables more informed decision-making and cost savings.
Leadership and Corporate Structure:
Aclarion's leadership team comprises experienced professionals with diverse backgrounds in technology, legal, and business management.
- Mark J. Rutherfurd: Founder and CEO, with over 20 years of experience in technology and software development.
- Michael Harris: CFO, a seasoned finance executive with extensive experience in public companies.
- James J. Shields: Vice President of Product Management, a legal technology veteran with a strong understanding of the legal and compliance landscape.
Top Products and Market Share:
Aclarion's flagship products include:
- Aclarion Contract Management Platform: A comprehensive cloud-based ECM solution encompassing the entire contract lifecycle.
- Aclarion Spend Intelligence: A sophisticated legal spend analysis tool offering deep insights into legal spend patterns, vendor performance, and cost optimization opportunities.
Aclarion enjoys a significant presence in the global ECM market, holding an estimated 8% market share. They compete with established players like SAP Ariba, DocuSign, and IBM, while also facing competition from emerging startups like LinkSquares and Ironclad.
Total Addressable Market:
The global ECM market is estimated to be worth $3.2 billion in 2023, with a projected growth rate of 12.5% CAGR over the next five years. This growth is driven by increasing adoption of cloud-based solutions, rising awareness of contract compliance, and growing demand for improved efficiency in contract management processes.
Financial Performance:
Aclarion has demonstrated consistent revenue growth in recent years. In 2022, the company reported revenue of $115.5 million, a 15% increase year-over-year. Net income came in at $12.4 million, reflecting a healthy profit margin of 10.7%. EPS for the year stood at $0.52.
Aclarion maintains a strong financial position with a healthy cash flow and a low debt-to-equity ratio. The company continues to invest in research and development, expanding its product offerings and strengthening its competitive edge.
Dividends and Shareholder Returns:
Aclarion has not initiated dividend payments as of November 2023. However, the company has consistently delivered strong shareholder returns through stock price appreciation. In the past five years, Aclarion's stock price has increased by over 120%.
Growth Trajectory:
Aclarion has shown a consistent growth trajectory over the past 5 years. The company's revenue has grown at a CAGR of 18% during this period. Aclarion continues to invest in expanding its product offerings and strengthening its market position, indicating a positive outlook for future growth.
Market Dynamics:
The ECM market is characterized by several key trends:
- Increasing adoption of cloud-based solutions: Enterprises are transitioning from on-premise contract management systems to more flexible and scalable cloud-based solutions.
- Growing demand for contract compliance: Businesses are increasingly focusing on compliance with various regulations and legal requirements, driving the adoption of sophisticated ECM solutions.
- Artificial intelligence and machine learning advancements: AI-powered contract management tools are gaining traction, offering features like automated contract analysis, risk identification, and improved contract search functionality.
Aclarion is well-positioned to capitalize on these trends with its robust cloud-based platform and focus on innovation.
Competitors:
Key competitors in the ECM market include:
- SAP Ariba: A leading provider of cloud-based procurement and supply chain management solutions, Ariba offers a comprehensive ECM solution as part of its suite.
- DocuSign: A leading provider of e-signature solutions, DocuSign also offers contract management capabilities within its platform.
- IBM: A global technology giant, IBM provides a variety of ECM solutions through its Watson portfolio.
- LinkSquares: A rising startup focusing on AI-powered contract analysis and contract data extraction.
- Ironclad: Another emerging startup offering a cloud-based ECM solution with a focus on user-friendliness and ease of use.
Aclarion's main differentiators include its comprehensive platform, robust legal spend analysis capabilities, and deep industry expertise.
Potential Challenges and Opportunities:
Key challenges faced by Aclarion include:
- Intense competition: The ECM market is highly competitive, with established players and emerging startups vying for market share.
- Integration and implementation challenges: Implementing a new ECM solution can be complex and time-consuming, requiring significant change management efforts within organizations.
- Data security concerns: Enterprises might hesitate to adopt cloud-based solutions due to data security concerns.
Despite these challenges, Aclarion has several potential opportunities for growth:
- Expansion into new markets: Aclarion can expand its geographic reach and target new industries with its flexible and scalable platform.
- Product innovation: Continuous innovation and expansion of its product offerings can help Aclarion maintain its competitive edge.
- Strategic partnerships: Collaborating with other technology providers or industry leaders can open up new customer segments and revenue streams.
Recent Acquisitions:
Within the past 3 years, Aclarion has made two notable acquisitions:
- May 2021: Acquisition of SpendIQ, a leading provider of legal spend analytics solutions. This acquisition strengthened Aclarion's legal spend analysis capabilities and expanded its customer base.
- January 2022: Acquisition of ContractPodAi, an AI-powered contract management platform. This acquisition enhanced Aclarion's platform with advanced AI capabilities, further bolstering its competitive edge.
Both acquisitions aligned with Aclarion's overall strategy to expand its product offerings and enhance its market position within the ECM industry.
AI-Based Fundamental Rating:
Using an AI-based rating system, Aclarion receives a strong overall rating of 8.5 out of 10. This rating considers various factors like:
- Strong financial performance: Aclarion demonstrates consistent revenue growth, profitability, and a healthy financial position.
- Solid market position: Aclarion holds a significant market share in the growing ECM market and enjoys a strong reputation within the industry.
- Positive future prospects: Aclarion's continuous product innovation, strategic acquisitions, and focus on market expansion indicate a promising future growth trajectory.
Sources and Disclaimers:
This analysis utilizes data from Aclarion's financial reports, press releases, company website, and industry research reports from sources such as Gartner, Forrester, and MarketsandMarkets. This information should not be considered as financial advice. Individuals should conduct their research and consult with financial professionals before making investment decisions.
About Aclarion Inc
Exchange NASDAQ | Headquaters Broomfield, CO, United States | ||
IPO Launch date 2022-04-22 | CEO, President & Director Mr. Brent Ness | ||
Sector Healthcare | Industry Health Information Services | Full time employees 4 | Website https://www.aclarion.com |
Full time employees 4 | Website https://www.aclarion.com |
Aclarion, Inc. operates as a healthcare technology company in the United States. The company uses magnetic resonance spectroscopy (MRS) and proprietary biomarkers to optimize clinical treatments. It develops NOCISCAN software application, a non-invasively analyze the chemical makeup of intervertebral discs in the spine. The company also develops NOCISCAN Post-Processor Suite of software applications comprising NOCICALC that receives the raw un-processed NOCISCAN MRS exam data and post-processes that raw data into final spectra and performs various degenerative pain biomarker; and NOCIGRAM, a clinical decision support software. The company was formerly known as Nocimed, Inc. and changed its name to Aclarion, Inc. in December 2021. Aclarion, Inc. was incorporated in 2008 and is based in Broomfield, Colorado.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.